TL;DR
- Bio Protocol has launched the Bio V1 update, which uses artificial intelligence and blockchain to transform the funding of scientific research.
- The update introduces the BioDAO Launchpad, which allows research projects to register directly on the platform.
- Bio V1 also introduces BioAgents, AI systems that assist in scientific tasks and reduce product development costs.
Bio Protocol has launched an update to its platform, called Bio V1, which aims to transform the way scientific research is funded using artificial intelligence and blockchain technology.
This update, available on the Base and Solana networks, marks a significant evolutionary leap for the protocol, transitioning from an off-chain accelerator to a decentralized permissionless financial layer to fund decentralized science (DeSci) projects.
Bio Protocol Launches BioDAO Launchpad
One of the most important changes in Bio V1 is the launch of BioDAO Launchpad, which replaces the former accelerator model. Now, research projects can register directly on the platform and go through three stages: Curation, Funding, and Liquidity.
In the first stage, participants back projects by staking BIO tokens to vote on proposals. Then, in the funding phase, selected projects raise capital through auctions or bonding curves. Finally, the liquidity stage facilitates token generation and listings on decentralized exchanges.
Bio Protocol’s system has an automated approach where, if projects meet their funding thresholds, backers receive discounted tokens from the approved projects, while those backing unsuccessful bids can withdraw their locked tokens. This process aims to make the funding of scientific research more transparent and accessible, enabling anyone interested in innovative projects to participate.
BioAgents to Assist Scientists
In addition, Bio Protocol V1 introduces BioAgents, AI-based systems designed to assist with scientific tasks and reduce product development costs. These agents are essential for both the internal management of DAOs and for scientific analysis and intellectual property development within the platform.
The BIO token, which began its launch on the Ethereum network and debuted on Binance, has also gained more utility with this update. The revenue generated by the platform, including fees from the Launchpad and liquidity provision, will be used to strengthen the DeSci ecosystem and provide tools to researchers, patients, and cryptocurrency users to support scientific innovation from the start.
Bio Protocol raised over $30 million in 2024 and continues to drive funding for research in areas such as rare diseases and quantum biology.
